A Multicenter Cohort Study of the Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 03 Mar 2017
At a glance
- Drugs Micafungin (Primary) ; Antifungals
- Indications Mycoses
- Focus Adverse reactions
- Acronyms MYCOS
- Sponsors Astellas Pharma Europe Ltd
- 28 Feb 2017 Planned End Date changed from 1 Nov 2020 to 1 Nov 2019.
- 28 Feb 2017 Planned primary completion date changed from 1 Apr 2020 to 1 Nov 2019.
- 21 Oct 2015 Planned primary completion date changed to 1 Apr 2020.